glp-1 and gip hormones Science Behind GLP 1 Glucagon Receptor Agonists for Obesity Research | News & Announcements GIP and GLP‐1, the two

It also covers the extent of weight expected to be regained on cessation of treatment

You're below therapeutic threshold

some people feel no appetite at all, while others notice strong hunger on certain days

This evaluation may include: Review of all current medications and potential drug interactions Assessment of cardiovascular risk factors and metabolic health Hormone level testing if indicated Discussion of lifestyle factors and relationship dynamics Mental health screening Do not stop taking Saxenda without consulting your healthcare provider , as abrupt discontinuation may affect your weight management progress

But as evidence propositions they are worlds apart: one is an FDA-approved drug with replicated Phase 3 trials, the other is an unapproved research chemical with two small surrogate-marker studies and discontinued development